These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17877115)

  • 1. [The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma].
    Kupczyk M; Bogacka E; Bocheńska-Marciniak M; Sterchaluk-Grzyb E; Tworek D; Kuna P
    Pol Merkur Lekarski; 2005 Feb; 18(104):129-32. PubMed ID: 17877115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
    Dizdar EA; Sekerel BE; Keskin O; Kalayci O; Adalioglu G; Dogan C; Tuncer A
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
    Keith PK; Luciuk G
    Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
    Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
    Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
    Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
    Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE; Lumry WR; Anolik R
    J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
    Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Jensen CB; Fokkens WJ; Ring J; Keith P; Gopalan G; Lorber R; Zuberbier T;
    Int Arch Allergy Immunol; 2010; 153(4):395-402. PubMed ID: 20559006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE
    Allergy; 2001; 56 Suppl 65():21-7. PubMed ID: 11243501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
    Chervinsky P; Nayak A; Rooklin A; Danzig M
    Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD; Angello JT; Wu MM; Druce HM
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
    Horak F; Stübner P; Zieglmeyer R; Harris AG
    Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A; Neukirch C; Dreyfus I; Devillier P
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.